Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade

Authors: C Sotiriou, P Wirapati, S Loi, A Harris, J Bergh, J Smeds, V Praz, P Farmer, B Haibe-Kains, F Lallemand, M Buyse, M Piccart, M Delorenzi

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

The histological grade (HG) in breast cancer provides important prognostic information. However, its interobserver variability and poor reproducibility, especially for tumours of intermediate grade, have limited its clinical potential. We hypothesized that molecular characterization of the grade may allow for full exploitation of the association between the grade and relapse beyond the ability of traditional grading procedures. …
Metadata
Title
Gene expression profiling in breast cancer challenges the existence of intermediate histological grade
Authors
C Sotiriou
P Wirapati
S Loi
A Harris
J Bergh
J Smeds
V Praz
P Farmer
B Haibe-Kains
F Lallemand
M Buyse
M Piccart
M Delorenzi
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1163

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Poster Presentation

Identification of differentially expressed genes in canine mammary tumor cell lines using a newly developed canine-specific cDNA microarray

Poster Presentation

Imprint as a reliable diagnostic tool in breast cancer and possible usefulness for research purposes

Oral Presentation

TP53 and additional pathways in therapy resistance

Poster Presentation

Lymph node metastases display gene expression profiles of their primary breast carcinomas

Poster Presentation

Essential functions of the Janus kinase 2 (Jak2) during mammary gland development and tumorigenesis

Poster Presentation

Prognostic value genotypes and LOH at TP53 codon 72 and TP53mutations in primary breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits